Zimmer Biomet Holdings
$88.29Change from previous close: +0.26%Absolute change: +$0.23
Valuation
Data as of October 4, 2026
Valuation multiples
- Market cap
- $16.75B
- Enterprise value
- $23.94B
- P/E (trailing 12 months)
- 21.3
- Forward P/E
- 9.69
- PEG
- 0.55
- Price/book
- 1.33
- Price/sales
- 1.97
- EV/EBITDA
- 9.48
- EV/revenue
- 2.81
Profitability and growth
- Gross margin
- 69.5%
- Operating margin
- 18.0%
- Net margin
- 9.5%
- ROE
- 6.4%
- ROA
- 3.9%
- ROIC
- 6.2%
- Revenue growth (year over year)
- 4.8%
- Earnings growth (year over year)
- 33.8%
Financial health
- Total cash
- $464.5M
- Total debt
- $7.6B
- Debt/equity
- 0.60
- Current ratio
- 1.69
- Quick ratio
- 0.74
- Altman Z-Score
- 2.51
- Piotroski F-Score
- 6.00
Dividends
- Annual dividend per share
- $0.96
- Dividend yield
- 1.1%
- Payout ratio
- 23.3%
- Ex-dividend date
- September 30, 2026
Analysts and estimates
- Average price target
- $107.57
- Median price target
- $106.00
- High price target
- $130.00
- Low price target
- $93.00
- Analysts with a price target
- 21
- Consensus
- Buy
- Forward EPS
- $9.07
- EPS estimate, current year
- $8.53
Shares and trading
- Beta
- 0.47
- Average volume
- 2.16M
- Shares outstanding
- 190.74M
- Float
- 190.13M
- Institutional ownership
- 111.4%
- Insider ownership
- 0.2%
- Short interest (% of float)
- 5.9%
- Short ratio (days)
- 5.24